Obermatt
See Similar Stocks →

Hologic

NSQ:HOLX · US4364401012
Health Care Equipment & SuppliesLarge

360

53
Medium confidence — indicative
EV / EBIT69
Price / Owner Earnings38
Owner Earnings Yield65
Dividend Yield1
Price/Sales45
EV / Gross Profit41
Price/Book50
Return on Capital67
Cash Return on Capital83
Return on Equity53
EBIT Margin88
Gross Profitability32
Cash Conversion70
Accruals60
Owner Earnings Margin83
Sales growth37
Profit Growth29
Long-Term EPS Growth12
Owner Earnings Growth50
Reinvestment3
Price momentum75
Debt load46
Refinancing40
Debt Payback65
Liquidity85
Analyst ratings1
Expectations trend32
Market mood63
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Hologic clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePrivate Company
ExchangeNASDAQCM
Founded1985
Employees5,497
Websitehologic.com
ISINUS4364401012
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)S&P 500 (USA)D.J. US Health CareD.J. US Medical Equipment
Themes
Health DiagnosticsWomen's HealthReproductive HealthSurgeryBiomedical EngineeringInfectious DiseasesRespiratoryOsteoporosisOncologyArtificial IntelligenceBiotechnologyHealth CareWomens

Description

Hologic, Inc. operates as a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The company sells and se…

Analysis

Quality compounder

Hologic, Inc. is a quality compounder: a well-run business trading at a price that reflects what it is worth.

The price is fair. You pay 23.7× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone.

The trajectory is tepid and the balance sheet is sturdy. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
39
2023202420252026

All-time high

78

Aug 2024

All-time low

31

Jan 2024

Average rank

51

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
45
42
34
55
Price/Earnings
25
76
73
82
Price/Book
50
48
50
64
Dividend Yield
1
1
1
1
Value (overall)
28
55
26
40

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Hologic with its peers
Vivani Medical
NAQ:VANI
—
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Spectral AI
NAQ:MDAI
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Senseonics
NSQ:SENS
7
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SANUWAVE Health
NMQ:SNWV
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →